Inflammatory bowel disease

Pediatric Clinics of North America

Volumn 58, Issue 4, 2011, Pages 903-920

  Szigethy, Eva ^a,b   McLafferty, Laura ^a   Goyal, Alka ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Anxiety; Chronic physical illness; Depression; Health related quality of life; Inflammatory bowel disease; Psychotherapy

Indexed keywords

ADALIMUMAB; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; AZATHIOPRINE; BUDESONIDE; CERTOLIZUMAB PEGOL; CYTOKINE RECEPTOR ANTAGONIST; DESIPRAMINE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NATALIZUMAB; PAROXETINE; PHENELZINE; PSYCHOTROPIC AGENT; STEROID;

ABDOMINAL PAIN; ADULTHOOD; ANXIETY DISORDER; ATTITUDE TO HEALTH; ATTITUDE TO ILLNESS; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COGNITIVE THERAPY; CROHN DISEASE; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; EDUCATIONAL MOBILITY; ENTERITIS; FAMILY COPING; FAMILY FUNCTIONING; FAMILY INTERACTION; GASTROINTESTINAL SURGERY; HUMAN; HYPNOSIS; INSOMNIA; MENTAL DISEASE; MENTAL FUNCTION; MENTAL STRESS; MOON FACE; NARRATIVE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PSYCHOSOMATIC DISORDER; QUALITY OF LIFE; RESOURCE MANAGEMENT; REVIEW; SCHOOL REENTRY; SHORT STATURE; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STRIA; SUPPORT GROUP; TREATMENT PLANNING; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 80051673781     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.06.007     Document Type: Review

References (105)

1. Griffiths A.M. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 2004, 18:509-523.
2. Achkar J.P., Duerr R. The expanding universe of inflammatory bowel disease genetics. Curr Opin Gastroenterol 2008, 24:429-434.
3. Shih D.Q., Targan S.R., McGovern D. Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroenterol Rep 2008, 10:568-575.
4. Silverberg M.S., Cho J.H., Rioux J.D., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome association-wide study. Nat Genet 2009, 41:216-220.
5. Kugathasan S., Amre D. Inflammatory bowel disease-environmental modification and genetic determinants. Pediatr Clin North Am 2006, 53:727-749.
6. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078.
7. Kanai T., Nemoto Y., Kamada N., et al. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Curr Opin Gastroenterol 2009, 25:306-313.
8. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
9. Abraham C., Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. lnflamm Bowel Dis 2009, 15:1090-1100.
10. Sawczenko A., Sandhu B. Presenting features of inflammatory bowel diseases in children. Arch Dis Child 2003, 88:995-1000.
11. Vernier-Massouille G., Balde M., Salleron J. Natural history of pediatric Crohn's disease. A population-based cohort study. Gastroenterology 2008, 135:1106-1113.
12. Hyams J.S., Davis P., Grancher K. Clinical outcome of ulcerative colitis in children. J Pediatr 1996, 129:81-88.
13. Loftus E.V., Sandborn W.J. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002, 31:1-20.
14. Turunen P., Kolho K.L., Auvinen A., et al. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006, 12:677.
15. Van Limbergen J., Russell R.K., Drummond H.E., et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008, 135:1114-1122.
16. Sauer C.G., Kugathasa Subra Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Gastroenterol Clin North Am 2009, 38:611-628.
17. Smith P.A. Nutritional therapy for active Crohn's disease. World J Gastroenterol 2008, 14:4420-4423.
18. Borrelli O., Cordischi L., Cirulli M., et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006, 4:744-753.
19. Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007, (1). CD000542.
20. Schwartz M., Cohen R. Optimizing conventional therapy for inflammatory bowel disease. Curr Gastroenterol Rep 2008, 10:585-590.
21. Rutgeerts P., Vermeire S., Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009, 136:1182-1197.
22. Devlin S.M., Panaccione R. Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up. Gastroenterol Clin North Am 2009, 38:577-594.
23. Mamula P., Markowitz J.E., Baldassano R.N. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 2003, 32:967-995.
24. Lindfred H., Saalman R., Nilsson S., et al. IBD and self-esteem in adolescence. Acta Paediatr 2008, 97:201-205.
25. Mackner L.M., Crandall W., Szigethy E.M. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:239-244.
26. Engstrom I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol Psychiatry 1992, 33:563-582.
27. Engstrom I. Inflammatory bowel disease and social interaction in families with children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999, 28:S28-S33.
28. Akobeng A.K., Suresh-Babu M.V., Firth D., et al. Quality of life in children with Crohn's disease: A Pilot Study. J Pediatr Gastroenterol Nutr 1999, 29:S37-S39.
29. Griffiths A.M., Nicholas D., Smith C., et al. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999, 28:S46-S52.
30. Rabbett H., Elbadri A., Thwaites R., et al. Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996, 23:528-533.
31. Lavigne J.V., Faier-Routman J. Psychological adjustment to pediatric physical disorders: a meta-analytic review. J Pediatr Psychol 1992, 17:133-157.
32. Burke P., Meyer V., Kocoshis S., et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989, 28:948-951.
33. Burke P., Kocoshis S.A., Chandra R., et al. Determinants of depression in recent onset pediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1990, 29:608-610.
34. Raymer D., Weininger O., Hamilton J.R. Psychological problems in children with abdominal pain. Lancet 1984, 1:439-440.
35. Szigethy E., Levy-Warren A., Whitton S., et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr 2004, 39:395-403.
36. Mackner L.M., Crandall W. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr 2007, 19:548-552.
37. Szigethy E., Carpenter J., Baum E., et al. Case study: longitudinal treatment of adolescents with depression and inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 2006, 45:396-400.
38. Szigethy E., Low C. Cytokines and depression. International encyclopedia of depression 2009, 200-204. Springer Publishing Co, New York. R.E. Ingram (Ed.).
39. Karwowski C., Richardson A., Kirshner M.A., et al. Characterizing depression in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009, 49(Suppl 1):E60.
40. Mackner L.M., Crandall W.V. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol 2005, 100:1386-1392.
41. Mrakotsky C., Bousvaros A., Chriki L., et al. Impact of acute steroid treatment on memory, executive function, and mood in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2005, 41:540-541.
42. Ranjbaran Z., Keefer L., Farhadi A., et al. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol 2007, 22:1748-1753.
43. Ananthakrishnan A.N., Issa M., Barboi A., et al. Impact of autonomic dysfunction on inflammatory bowel disease. J Clin Gastroenterol 2009, Sept 1, [online].
44. Ansari R., Attari F., Razjouyan H., et al. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life. Eur J Gastroenterol Hepatol 2008, 20:46-50.
45. Faure C., Giguère L. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn's disease. Inflamm Bowel Dis 2008, 14:1569-1574.
46. Kane S.V. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:577-585.
47. Mackner L., Crandall W. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:1006-1012.
48. Vlahou C.H., Cohen L.L., Woods A.M., et al. Age and body satisfaction predict diet adherence in adolescents with inflammatory bowel disease. J Clin Psychol Med Settings 2008, 15:278-286.
49. Hommel K., Davis C., Baldassano R. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol 2008, 33:867-874.
50. Janicke D.M., Gray W.N., Kahhan N.A., et al. Brief report: the association between peer victimization, prosocial support, and treatment adherence in children and adolescents with inflammatory bowel disease. J Pediatr Psychol 2009, 34:769-773.
51. Camara R.J., Ziegler R., Begré S., et al. The role of psychological stress in inflammatory bowel disease: quality assessment of methods 18 prospective studies and suggestions for future research. Digestion 2009, 80:129-139.
52. Singh S., Graff L.A., Bernstein C.N. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?. Am J Gastroenterol 2009, 104:1298-1313.
53. Graff L.A., Walker J.R., Bernstein C.N. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009, 15:1105-1118.
54. Ghia J.E., Blennerhassett P., Deng Y., et al. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009, 136:2280-2288.
55. Nicholas D.B., Otley A., Smith C., et al. Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination. Health Qual Life Outcomes 2007, 5:28.
56. Reichenberg K., Lindfred H., Saalman R. Adolescents with inflammatory bowel disease feel ambivalent towards their parents' concern for them. Scand J Caring Sci 2007, 21:476-481.
57. Nicholas D.B., Swan S.R., Gerstle T.J., et al. Struggles, strengths, and strategies: an ethnographic study exploring the adolescents living with an ostomy. Health Qual Life Outcomes 2008, 6:114.
58. Irvine E.J. Quality of life issues in patients with inflammatory bowel disease. Am J Gastroenterol 1997, 92(Suppl 12):18S-24S.
59. Boye B., Jahnsen J., Mokleby K., et al. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?. Inflamm Bowel Dis 2008, 14:680-686.
60. Maunder R., Esplen M.J. Facilitating adjustment to inflammatory bowel disease: a model of psychosocial intervention in non-psychiatric patients. Psychother Psychosom 1999, 68:230-240.
61. Guyatt G., Mitchell A., Irvine E.J., et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
62. Griffiths A.M., Otley A.R., Hyams J., et al. A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis 2005, 11:185-196.
63. Perrin J.M., Kuhlthau K., Chughtai A., et al. Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr 2008, 46:164-171.
64. Blank C., Switzer G. The use of questionnaires in pediatric inflammatory bowel disease. Curr Gastroenterol Rep 2006, 8:242-245.
65. Taft T., Keefer L., Leonhard C., et al. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis 2009, 15:1224-1232.
66. Drossman D.A., Patrick D.L., Mitchell C.M., et al. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci 1989, 34:1379-1386.
67. Otley A.R., Griffiths A.M., Hale S., et al. Healthy-related quality of life in the first year after diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:684-691.
68. Turunen P., Ashorn M., Auvinen A., et al. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009, 15:56-62.
69. Upton P., Eiser C., Cheung I., et al. Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes 2005, 3:22.
70. Lynch T., Spence D. A qualitative study of youth living with Crohn's disease. Gastroenterol Nurs 2008, 31:224-230.
71. Tojek T.M., Lumley M.A., Corlis M., et al. Maternal correlates of health status in adolescents with inflammatory bowel disease. J Psychosom Res 2002, 52:173-179.
72. Engstrom I. Parental distress and social interaction in families with children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991, 30:904-912.
73. Savard J., Woodgate R. Young peoples' experience of living with ulcerative colitis and an ostomy. Gastroenterol Nurs 2009, 32:33-41.
74. Tuchman L.K., Slap G.B., Britto M.T. Transition to adult care: experiences and expectations of adolescents with a chronic illness. Child Care Health Dev 2008, 34:557-563.
75. Adler J., Raju S., Beveridge A.S., et al. College adjustment in University of Michigan students with Crohn's and colitis. Inflamm Bowel Dis 2008, 14:1281-1286.
76. Fletcher P., Schneider M., Van Ravenswaay V., et al. I am doing the best that I can!: living with inflammatory bowel disease and/or irritable bowel syndrome (part II). Clin Nurse Spec 2008, 22:278-285.
77. Mikocka-Walus A.A., Turnbull D.A., Moulding N.T., et al. "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspective on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol 2007, 7:38.
78. Mikocka-Walus A.A., Turnbull D.A., Moulding N.T., et al. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemol Ment Health 2006, 2:24.
79. Varghese A.K., Verdù E.F., Berick P., et al. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 2006, 130:1743-1753.
80. Kane S., Altschuler E.L., Kast R.E. Crohn's disease remission on bupropion. Gastroenterology 2003, 125:1290.
81. Karwowski C.A., Keljo D., Szigethy E.M. Strategies to improve quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:1755-1764.
82. Casellas F., Fontanet G., Borruel N., et al. The opinion of patients with inflammatory bowel disease on healthcare received. Rev Esp Enferm Dig 2004, 96:174-184.
83. Moser G., Tillinger W., Sachs G., et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995, 7:853-858.
84. Waters B.M., Jensen L., Fedorak R.N. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005, 19:235-244.
85. Larsson K., Sundberg H.M., Karlborn U., et al. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol 2003, 38:763-769.
86. Kennedy A.P., Nelson E., Reeves D., et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004, 53:1639-1645.
87. Garcia-Vega E., Fernandez-Rodriguez C. A stress management program for Crohn's disease. Behav Res Ther 2004, 42:367-383.
88. Oxelmark L., Magnusson A., Löfberg R., et al. Group-based intervention program in inflammatory bowel disease patients: effects on quality of life. Inflamm Bowel Dis 2007, 13:182-190.
89. Grootenhuis M.A., Maurice-Stam H., Derkx B.H., et al. Evaluation of a psychoeducational intervention for adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2009, 21:430-435.
90. Szigethy E., Kenney E., Carpenter J., et al. Cognitive behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry 2007, 46:1290-1298.
91. Szigethy E., Craig A.E., Iobst E.A., et al. Profile of depression in adolescents with inflammatory bowel disease: implications for treatment. Inflamm Bowel Dis 2009, 15:69-74.
92. Weisz J.R., McCabe M.A., Dennig M.D. Primary and secondary control among children undergoing medical procedures: adjustment as a function of coping style. J Consult Clin Psychol 1994, 62:324-332.
93. Weinman J., Petrie K.J., Moss-Morris R., et al. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health 1996, 11:431-440.
94. Bers M.U., Gonzalez-Heydrich J., Demaso D.R. Use of a computer-based application in a pediatric hemodialysis unit: a pilot study. J Am Acad Child Adolesc Psychiatry 2003, 42:493-496.
95. De Maso D.R., Marcus N.E., Kinnamon C., et al. Depression experience journal: a computer-based intervention for families facing childhood depression. J Am Acad Child Adolesc Psychiatry 2006, 45:158-165.
96. Miller V., Whorwell P.J. Treatment of inflammatory bowel disease: a role for hypnotherapy?. Int J Clin Exp Hypn 2008, 56:306-317.
97. Keefer L., Keshavarzian A. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int J Clin Exp Hypn 2007, 55:457-466.
98. Emami M.H., Gholamrezaei A., Daneshgar H. Hypnotherapy as an adjuvant for the management of inflammatory bowel disease: a case report. Am J Clin Hypn 2009, 51:255-262.
99. Mawdsley E., Jenkins D.G., Macey M.G., et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 2008, 103:1460-1469.
100. Shaoul R., Sukhotnik I., Mogilner J. Hypnosis as an adjuvant treatment for children with inflammatory bowel disease. J Dev Behav Pediatr 2009, 30:268.
101. Vlieger A.M., Menko-Frankenhuis C., Wolfkamp S.C., et al. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology 2007, 133:1430-1436.
102. Oliveira S., Zaltman C., Elia C., et al. Quality-of-life measurement in patients with inflammatory bowel disease receiving social support. Inflamm Bowel Dis 2007, 13:470-474.
103. Shepanski M.A., Hurd L.B., Culton K., et al. Health-related quality of life improves in children and adolescents with inflammatory bowel disease after a camp sponsored by the Crohn's and Colitis Foundation of America. Inflamm Bowel Dis 2005, 11:164-170.
104. Szigethy E., Hardy D., Craig A.E., et al. Girls connect: effects of a support group for teenage girls with inflammatory bowel disease and their mothers. Inflamm Bowel Dis 2009, 15:1127-1128.
105. Jaff J.C., Arnold J., Bousvaros A. Effective advocacy for patients with inflammatory bowel disease: communication with insurance companies, school administrators, employers, and other health care overseers. Inflamm Bowel Dis 2006, 12:814-823.